Key result
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV.
Why the study?
Does rosuvastatin reduce arterial stiffness in men with HIV?
Does rosuvastatin reduce arterial stiffness in men with HIV?
Answers are grounded in this paper and cite their sources.
Rosuvastatin does not appear to reduce arterial stiffness in men with HIV and may be linked to cardiometabolic adverse events.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Muchaili et al. (2024) studied this question. Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV.
Synapse has enriched 10 related papers. Consider them for comparative context: